Seyedali Seyedmajidi

Dr. Seyedali Seyedmajidi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Journal of Laboratory Physicians
Verified
Journal Article
Open access
PDF file
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi
RRRamazan Rajabnia
Ramazan Rajabnia
MSMaryam Seyedmajidi
Maryam Seyedmajidi
AIMS AND OBJECTIVES: Infection is a serious problem for patients after implantation surgery, which is difficult to treat with antibiotic therapy. The present study was developed to evaluate and compare the antibacterial properties of hydroxyapatite/bioactive glass (HA/BG) and fluorapatite/bioactive glass (FA/ BG) nanocomposite foams as a cellular scaffold for use in bone defects by two macrodilution and disk diffusion methods. MATERIALS AND METHODS: Staphylococcus aureus, Enterococcus faecalis, and Streptococcus mutans were cultured in brain heart infusion broth medium with nanocomposite powder for 5 days, and their bioactivity levels were evaluated by daily culturing on solid agar medium plates. To carry out the disk diffusion test, a disc form of nanocomposite foams was used on agar medium with 48 h incubation. Results: None of two nanocomposites even at their highest concentration (200 mg/mL) did not prevent the growth of two Staphylococcus aureus and Enterococcus faecalis microorganisms. However, HA/BG nanocomposite on the 3rd day at a concentration of 200 mg/mL and on 4th and 5th day at a concentration of 100 mg/mL and FA/BG nanocomposite on the 4th day at a concentration of 100 mg/mL and on the 5th day at a concentration of 50 mg/mL could be able to kill Streptococcus mutans microorganism. In the disc diffusion test, none of the nanocomposites could create a nongrowth zone. Both tested biomaterials showed increased antibacterial properties over time and concentration increase. Conclusions: HA/BG and FA/BG nanocomposites, due to their biocompatibility and antimicrobial properties, are good choices for implantation instead of damaged bone tissue in tissue engineering.

5 January 2024 in Evidence-Based Dentistry
Verified
Journal Article
Closed access
PDF file
SKSareh Kachabian
Sareh Kachabian
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi
BTBahareh Tahani
Bahareh Tahani
MNMehdi Naghibi
Mehdi Naghibi

8 September 2018 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi
MSMaryam Seyedmajidi
Maryam Seyedmajidi
EZEbrahim Zabihi
Ebrahim Zabihi
KHKarimollah Hajian‐Tilaki
Karimollah Hajian‐Tilaki

24 January 2025 in Orthodontics & Craniofacial Research
Verified
Journal Article
Closed access
MGMahnaz Gharibnavaz
Mahnaz Gharibnavaz
VAValiollah Arash
Valiollah Arash
APAbazar Pournajaf
Abazar Pournajaf
FNFarhood Najafi
Farhood Najafi
MKManouchehr Rahmati Kamel
Manouchehr Rahmati Kamel
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi

1 January 2016 in Journal of Research in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
JVJamshid Vafaeimanesh
Jamshid Vafaeimanesh
MSMohammadreza Seyyedmajidi
Mohammadreza Seyyedmajidi
AAAnahita Ahmadi
Anahita Ahmadi
SHShahin Hajiebrahimi
Shahin Hajiebrahimi
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi
MFMona Firoozabadi
Mona Firoozabadi
Objective: Proton pump inhibitor-based triple therapy with two antibiotics for Helicobacter pylori eradication is widely accepted, but this combination fails in a considerable number of cases. Some studies have shown that cranberry inhibits the adhesion of a wide range of microbial pathogens, including H. pylori. The aim of this study was to assess the effect of cranberry on H. pylori eradication with a standard therapy including lansoprazole, clarithromycin, and amoxicillin (LCA) in patients with peptic ulcer disease (PUD). Methods: In this study, H. pylori-positive patients with PUD were randomized into two groups: Group A: A 14-day LCA triple therapy with 30 mg lansoprazole bid, 1000 mg amoxicillin bid, and 500 mg clarithromycin bid; Group B: A 14-day 500 mg cranberry capsules bid plus LCA triple therapy. A 13C-urea breath test was performed for eradication assessment 6 weeks after the completion of the treatment. Findings: Two hundred patients (53.5% males, between 23 and 77 years, mean age ± standard deviation: 50.29 ± 17.79 years) continued treatment protocols and underwent 13C-urea breath testing. H. pylori eradication was achieved in 74% in Group A (LCA without cranberry) and 89% in Group B (LCA with cranberry) (P = 0.042). Conclusion: The addition of cranberry to LCA triple therapy for H. pylori has a higher rate of eradication than the standard regimen alone (up to 89% and significant).

1 November 2018 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SSSeyedali Seyedmajidi
Seyedali Seyedmajidi
MSMaryam Seyedmajidi
Maryam Seyedmajidi
RFRamin Foroughi
Ramin Foroughi
AZAmir Zahedpasha
Amir Zahedpasha
ZSZahra Zolfaghari Saravi
Zahra Zolfaghari Saravi
AMAmrollah Mostafazadeh
Amrollah Mostafazadeh
The most common type of oral cancer is oral squamous cell carcinoma. If it is diagnosed in the early stages; the success of the treatment can be increased. It seems that ELISA-based techniques as a screening tool for society are the most cost-effective methods for early diagnosis. CD44 is a key marker for the detection of SCC stem cells. The aim of this study was to compare the level of soluble CD44 in saliva and serum between patients with oral SCC and healthy controls. Saliva and serum were collected from 20 patients with primary OSCC and 20 healthy persons as control group. The samples were evaluated by an ELISA test kit. Data were analyzed by SPSS software version 22, chi-square, ANOVA, T-test and Spearman correlation test. The mean of soluble CD44 level in serum and saliva of the patient and control groups are 531.51±228.95 and 453.3±113.74 (for serum) and 48.53±59.02 and 17.76±39.14 (for saliva) respectively. There was no statistically significant difference in serum and saliva solCD44 level between the patient and control groups (P value = 0.182 and P value = 0.061 respectively). Also, there was no significant correlation between the solCD44 level in each patient and control group in serum (P value = 0.61) and in saliva (P value = 0.445). Determination of solCD44 level in saliva and serum can be a useful method for diagnosis the person’s involvement with cancer cells and the cancer in the early stages. But according to the controversial outcomes of past studies, larger and more accurate studies are needed in groups with more cases of oral cancer.